Biogen Idec - McKnight's Long Term Care News

Biogen Idec

Clinical briefs for Thursday, July 15

FDA adds provider warning to J&J vaccine regarding rare neurological disorder … Biogen’s dementia drug Aduhelm could cost Medicaid up to $2.2 billion a year … Biden to nominate West Virginia’s Rahul Gupta as drug czar … Antibiotic stewardship lowers outpatient prescribing in VA facilities program … Skip azithromycin as treatment in mild COVID-19, researchers say … HHS provides $398M to small rural hospitals for COVID-19 testing, mitigation

Clinical briefs for Monday, Feb. 1

Advocates make fresh plea for prioritizing independent living in COVID vaccination clinics … Eli Lilly to test its approved antibody therapy against new COVID variants … FDA extends review for Biogen’s Alzheimer’s drug to June, signaling a chance for approval … HHS expands pool of clinicians who can administer COVID vaccinations … CDC posts COVID…

Clinical Briefs for Wednesday, August 12

Antibody drugs may have missed window to slow pandemic … FDA agrees to conduct quick review of Biogen’s Alzheimer’s drug … Atrial fibrillation deaths lowest in 45 years, but remain cause for concern … Asthma not a risk factor for severe pneumonia in COVID-19, study finds

Next post in Clinical Daily News